{"schema_version":"secwatch.filing_event.v1","accession":"0000937556-23-000215","form_type":"8-K","ticker":"MASI","cik":"0000937556","company_name":"MASIMO CORP","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.465398+00:00","generated_at":"2026-06-08T18:44:59.122351+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Masimo Q3 rev $478.9M, GAAP EPS $0.20; Q4 guide rev $526-$576M","bullets":["Q3 consolidated rev $478.9M: healthcare $307.8M, non-healthcare $171.1M.","GAAP net income $10.6M ($0.20 diluted); non-GAAP net income $33.7M ($0.63).","Q4 2023 guidance: rev $526-$576M, healthcare $320-$345M, non-healthcare $206-$231M.","FY 2023 guidance updated: rev $2,025-$2,075M, non-GAAP EPS $2.85-$3.05.","CEO: returning to pre-COVID growth trend; record contracting supports strong 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000937556-23-000215","json":"https://secwatch.observer/filing/0000937556-23-000215.json","markdown":"https://secwatch.observer/filing/0000937556-23-000215.md","text":"https://secwatch.observer/filing/0000937556-23-000215.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/937556/000093755623000215/0000937556-23-000215-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/937556/000093755623000215/masi-20231107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T18:44:59.122351+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"17cbb314231837cb442ca0903e6ad1d2aeb730f1","claim":"MASIMO CORP reported third quarter of 2023, ended September 30, 2023 results: net income $10.6 million, EPS $0.20 per diluted share.","evidence_excerpt":"Consolidated GAAP net income was $10.6 million, or $0.20 per diluted share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/937556/000093755623000215/0000937556-23-000215-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter of 2023, ended September 30, 2023"},{"label":"Net income","value":"$10.6 million"},{"label":"EPS","value":"$0.20 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"349d53a4742889848b0a521e4024793b663e9e51","claim":"MASIMO CORP reported Fourth-Quarter 2023 and Full-Year 2023 results: revenue Consolidated revenue $526 to $576 (Q4), Full-Year $2,025 to $2,075, EPS Consolidated net income per diluted share $0.45 to $0.65 (Q4 GAAP), $1.34 to $1.54 (Full-Year GAAP). Guidance reaffirmed.","evidence_excerpt":"The Company provided the following updated estimates for its fourth-quarter 2023 and full-year financial guidance: Guidance Fourth-Quarter 2023 (1) Updated Full-Year 2023 (1) (in millions, except earnings per diluted share) GAAP Non-GAAP GAAP Non-GAAP Consolidated revenue $526 to $576 $526 to $576 $2,025 to $2,075 $2,025 to $2,075","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/937556/000093755623000215/0000937556-23-000215-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Fourth-Quarter 2023 and Full-Year 2023"},{"label":"Revenue","value":"Consolidated revenue $526 to $576 (Q4), Full-Year $2,025 to $2,075"},{"label":"EPS","value":"Consolidated net income per diluted share $0.45 to $0.65 (Q4 GAAP), $1.34 to $1.54 (Full-Year GAAP)"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}